2005
DOI: 10.1081/clt-50414
|View full text |Cite
|
Sign up to set email alerts
|

Hexavalent Chromium Ingestion: Biological Markers of Nephrotoxicity and Genotoxicity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0
2

Year Published

2013
2013
2021
2021

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(7 citation statements)
references
References 9 publications
0
5
0
2
Order By: Relevance
“…Accidental ingestion has been reported for Cr(VI) compounds including chromic acid (Fristedt et al, 1965;Saryan and Reedy, 1988;Loubières et al, 1999), potassium chromate (Goldman and Karotkin, 1935;Partington, 1950;Kaufman et al, 1970;Sharma et al, 1978;Iserson et al, 1983;Clochesy, 1984;Hanston et al, 2005), and ammonium dichromate (Reichelderfer, 1968;Hasan, 2007) resulting in a large variety of clinical presentations such as abdominal pain, nausea, and vomiting; hematemesis and bloody diarrhea; caustic burns of the mouth, pharynx, esophagus, stomach, and duodenum and GI hemorrhage; anemia, decreased blood Hb, abnormal erythrocytes, and intravascular hemolysis; hepatotoxicity (hepatomegaly, jaundice, elevated blood bilirubin, and liver enzymes activities); renal failure (oliguria and anuria); cyanosis; and metabolic acidosis, hypotension, and shock (see also ATSDR, 2012). Fatty degeneration in the liver and tubular degeneration and necrosis in the kidney were observed in biospies (Reichelderfer, 1968;Kaufman et al, 1970;Sharma et al, 1978;Loubières et al, 1999).…”
Section: Acute Oral Toxicitymentioning
confidence: 99%
“…Accidental ingestion has been reported for Cr(VI) compounds including chromic acid (Fristedt et al, 1965;Saryan and Reedy, 1988;Loubières et al, 1999), potassium chromate (Goldman and Karotkin, 1935;Partington, 1950;Kaufman et al, 1970;Sharma et al, 1978;Iserson et al, 1983;Clochesy, 1984;Hanston et al, 2005), and ammonium dichromate (Reichelderfer, 1968;Hasan, 2007) resulting in a large variety of clinical presentations such as abdominal pain, nausea, and vomiting; hematemesis and bloody diarrhea; caustic burns of the mouth, pharynx, esophagus, stomach, and duodenum and GI hemorrhage; anemia, decreased blood Hb, abnormal erythrocytes, and intravascular hemolysis; hepatotoxicity (hepatomegaly, jaundice, elevated blood bilirubin, and liver enzymes activities); renal failure (oliguria and anuria); cyanosis; and metabolic acidosis, hypotension, and shock (see also ATSDR, 2012). Fatty degeneration in the liver and tubular degeneration and necrosis in the kidney were observed in biospies (Reichelderfer, 1968;Kaufman et al, 1970;Sharma et al, 1978;Loubières et al, 1999).…”
Section: Acute Oral Toxicitymentioning
confidence: 99%
“…До широко розповсюджених і небезпечних ксенобіотиків належать солі важких металів (Porter et al, 2005). Отруєння ними може спричинити порушення метаболічних процесів, важкі захворювання (Duffus, 2002;Hantson et al, 2005). Згідно з деякими прогнозами, в майбутньому сполуки важких металів як загроза екологічному стану довкілля можуть вийти на перше місце, випереджаючи в цьому відношенні відходи атомних станцій та органічні антропогенні забруднення (Banfalvi, 2011).…”
Section: вступunclassified
“…A DMPS challenge failed to show any increase in chromium excretion [107]. As adjuvant therapy in patients who were exposed, NAC did not demonstrate any particular benefit, although it was without apparent toxicity [102,108].…”
Section: Chromium Chelators and Chelation Considerationsmentioning
confidence: 99%
“…The data regarding the effectiveness of hemodialysis are mixed; it also may be instituted for concurrent renal failure [101,102,109,110]. Ascorbic acid has been added as a nonspecific antioxidant in addition to multiple therapeutic measures, making determination of its individual contribution difficult in humans [101,108].…”
Section: Chromium Chelators and Chelation Considerationsmentioning
confidence: 99%